Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/1999
02/11/1999DE19733389A1 Mittel zur Expression und zum Nachweis eines ein HPOL-Epitop und ein Polypeptid umfassenden Fusionspolypeptids Means for expression and detection of a HPOL epitope and a polypeptide comprising the fusion polypeptide
02/11/1999DE19729591A1 Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen Agents for the treatment and / or prophylaxis of microcirculation disorders
02/11/1999DE19728737C1 Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten A method for the detection and determination of GnRH receptors and the use of GnRH agonists and GnRH-antagonists for the treatment of a tumor originating in the brain and / or nervous system and / or the meninges
02/11/1999CA2493240A1 Methods for detecting or assaying virus
02/11/1999CA2338865A1 Methods for detecting binding events using multiple binding partners and muliple targets
02/11/1999CA2299623A1 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs
02/11/1999CA2299276A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides
02/11/1999CA2299256A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides
02/11/1999CA2299055A1 Novel molecules of the tango-77 related protein family and uses thereof
02/11/1999CA2298852A1 83 human secreted proteins
02/11/1999CA2298766A1 Human longevity-assurance protein homologs
02/11/1999CA2298573A1 Synaptojanin isoform
02/11/1999CA2298538A1 Recombinant dimeric envelope vaccine against flaviviral infection
02/11/1999CA2297745A1 Oxidized styrenic polymers for dna binding
02/11/1999CA2297555A1 Collagen-peptide assay method
02/11/1999CA2297489A1 Novel bone mineralization proteins, dna, vectors, expression systems
02/11/1999CA2294650A1 Starch debranching enzymes
02/11/1999CA2239836A1 Novel arginine deiminase
02/11/1999CA2239813A1 Novel nrdd
02/10/1999EP0896061A2 RpoA gene from Staphylococcus aureus
02/10/1999EP0896060A2 RpoA gene from Staphylococcus aureus
02/10/1999EP0896058A1 Novel semaphorin z and gene encoding the same
02/10/1999EP0896055A2 Apoptosis inducing protein and gene encoding the same
02/10/1999EP0895543A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
02/10/1999EP0556272B1 Therapeutic and diagnostic methods using total leukocyte surface antigens
02/10/1999CN1207811A Method of diagnosing and treating epithelioma
02/10/1999CN1207395A Anti-FAS antibodies
02/09/1999US5869640 Nucleic acids encoding D-type cyclins and hybridization probes
02/09/1999US5869638 Bone-related cadherin-like protein and process for its production
02/09/1999US5869637 Human Kallikrein
02/09/1999US5869636 Recombinant cell line expressing polypetide for anticarcinogenic and antitumor agents and vaccines
02/09/1999US5869622 Monoclonal antibodies to the pur protein
02/09/1999US5869621 A human antibody, expressed in the thymus, that binds an at rich sequence proteins in the nuclear scaffold; unwinding properties in relieving negative superhelical strains that occur in chromatin loops; use as probe for atc sequences
02/09/1999US5869620 Multivalent antigen-binding proteins
02/09/1999US5869619 Modified antibody variable domains
02/09/1999US5869618 For diagnosis of cancers related to erbb-2 oncogene expression
02/09/1999US5869612 Amino acid sequence of isolated protein involved in post-receptor signal transduction; treatment of rheumatoid arthritis and septic shock
02/09/1999US5869610 Isolated polypeptide identified as a cytokine receptor containing extracellular, transmembrane and intracellular domains; prenatal testing and cancer diagnosis
02/09/1999US5869609 G protein coupled glutamate receptors
02/09/1999US5869603 Amino acid sequences of synthetic peptides binding to neutralizing antibodies against recombinant interferon-beta; for detection and inhibition of antibodies in patients
02/09/1999US5869445 Methods for eliciting or enhancing reactivity to HER-2/neu protein
02/09/1999US5869349 Pretreatment with acid prior to immobilization on silaceous support increases antigen-binding capacity
02/09/1999US5869348 Methods for the preparation of antibodies directed against dithiocarbamates and the use thereof for detection of nitric oxide in body fluids
02/09/1999US5869333 Ryegrass pollen allergen
02/09/1999US5869331 Target cell specific chimeric spleen necrosis virus viral particles having antigenic binding and natural viral proteins; gene therapy
02/09/1999US5869292 Producing genetically engineered protein by replacing at least one acidic region of factor viii with acidic region of hirudin or heparin cofactor ii; increased coagulant activity
02/09/1999US5869290 Cayae1 polynucleotides
02/09/1999US5869286 Receptor that binds IL-17
02/09/1999US5869282 Nucleotide and protein sequences of the serrate gene and methods based thereon
02/09/1999US5869281 For culturing and screening for modulators of receptor; glucoma, synchronization of animal estrus cycles, antitumor and antiprolferative agents
02/09/1999US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase
02/09/1999US5869268 Anti-hanganutzui-deicher human monoclonal igg antibody; for anticarcinogenic and antitumors agents and diagnosis
02/09/1999US5869265 Screening modulators by contacting recombinant cells which express cotransporter with substance, determining increase or decrease in activity; anticholesterol agents; antidiabetic agents; liver disease; crohn's disease
02/09/1999US5869264 Immunoassays for and immunopurification of interferon-induced human protein
02/09/1999US5869263 Lymphocyte chemoattractant factor and uses thereof
02/09/1999US5869262 Quantitative immunoassay by contacting serum from patient with antibodies against circulating intercellular adhesion molecule-r, detecting binding; higher levels indicate progression of systematic lupus erythematosus
02/09/1999US5869235 Dna coding for the coat protein of virus isolated from infected vine plants; for detection of vrial infection by reverse transcription polymerase chain reaction and southern blotting
02/09/1999US5869232 Amino acid sequence of antibody binding to specific antigen (or hapten) covalently linked to second amino acid sequence to which a second antibody binds; redirecting specificity of antibody
02/09/1999US5869064 Protein rib, a cell surface protein that confers immunity to many strains of the group B Streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
02/09/1999US5869055 Anti-inflammatory CD14 polypeptides
02/09/1999US5869053 5T4 antigen from human trophoblasts
02/09/1999US5869050 Administering to patient antibody against b7 antigen and immunosuppressive agent in synergistic mixture; treatment of transplant rejection, graft versus host disease, rheumatoid arthritis
02/09/1999US5869049 Methods of inducing T cell unresponsiveness to bone marrow with gp39 antagonists
02/09/1999US5869048 Method of treating ulcerative colitis with a monoclonal antibody
02/09/1999US5869046 Altered polypeptides with increased half-life
02/09/1999US5869045 Polypeptide comprising antigen-binding region of monoclonal antibody produced by specified hybridoma
02/09/1999CA1340387C Heterobifunctional coupling agents
02/08/1999CA2239223A1 Novel rpoa
02/08/1999CA2239222A1 Novel rpoa
02/06/1999CA2239256A1 Novel lgt
02/05/1999CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses
02/05/1999CA2239270A1 Novel phosphoribosyl transferase
02/05/1999CA2238673A1 Novel aminopeptidase
02/05/1999CA2212315A1 Pharmaceutical composition with neurotrophic-like biological activity
02/04/1999WO1999005291A2 Aggrecan degrading metallo proteases
02/04/1999WO1999005282A1 Non-b non-c non-g hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus
02/04/1999WO1999005280A1 Mammalian cytokine: interleukin-b30 and related reagents
02/04/1999WO1999005275A1 Secreted proteins encoded by human chromosome 13
02/04/1999WO1999005261A1 Monospecific antibody reactive with matrix metalloproteinase cleavage products of fibrin(ogen)
02/04/1999WO1999005176A1 Monospecific antibody reactive with fibrinogen and fibrinopeptide b
02/04/1999WO1999005175A2 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1)
02/04/1999WO1999005174A1 The ha-1 antigen
02/04/1999WO1999005173A1 The ha-1 antigen
02/04/1999WO1999005171A1 NOVEL ESTROGEN RECEPTOR β AND ISOFORMS
02/04/1999WO1999005170A1 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS
02/04/1999WO1999005169A1 Epitopes of shigella like toxin and their use as vaccine and in diagnosis
02/04/1999WO1999004820A2 Cytolysis of target cells by superantigen conjugates inducing t-cell activation
02/04/1999WO1998051337A3 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
02/04/1999WO1998050433A3 Human monoclonal antibodies to epidermal growth factor receptor
02/04/1999WO1998050424A3 Human serine protease precursor
02/04/1999CA2298887A1 The ha-1 antigen
02/04/1999CA2298103A1 Non-b, non-c, non-g hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus
02/04/1999CA2298053A1 Novel estrogen receptor .beta. and isoforms
02/04/1999CA2297907A1 Human estrogen receptor beta
02/04/1999CA2296798A1 Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents
02/04/1999CA2296292A1 Secreted proteins encoded by human chromosome 13
02/04/1999CA2239267A1 Novel compounds
02/03/1999EP0894863A1 A YAK-1 related serine/threonine protein kinase-HTLAR33
02/03/1999EP0894862A2 Novel CysS
02/03/1999EP0894861A2 Glycogen phosphorylase from Streptococcus pneumoniae